EDAP
EDAP TMS SA

1,631
Mkt Cap
$123.02M
Volume
20,319.00
52W High
$3.45
52W Low
$1.21
PE Ratio
-5.67
EDAP Fundamentals
Price
$3.29
Prev Close
$3.21
Open
$3.20
50D MA
$2.44
Beta
0.69
Avg. Volume
48,531.32
EPS (Annual)
-$0.5517
P/B
4.49
Rev/Employee
$223,718.07
Loading...
Loading...
News
all
press releases
RBOT Enters Strategic Software Partnership to Streamline Development
Vicarious Surgical inks a software execution partnership to streamline development, cut costs and improve predictability.
Zacks·2d ago
News Placeholder
More News
News Placeholder
Short Interest in Edap Tms S.A. (NASDAQ:EDAP) Increases By 163.4%
Edap Tms S.A. (NASDAQ:EDAP - Get Free Report) was the target of a significant increase in short interest during the month of December. As of December 15th, there was short interest totaling 93,243...
MarketBeat·6d ago
News Placeholder
EW Wins FDA Approval for SAPIEN M3 as First Transseptal TMVR Therapy
Edwards Lifesciences wins FDA approval for SAPIEN M3, the first transseptal TMVR, expanding minimally invasive options for high-risk mitral regurgitation patients.
Zacks·6d ago
News Placeholder
Edap Tms (NASDAQ:EDAP) Stock Price Passes Above 200-Day Moving Average - What's Next?
Edap Tms (NASDAQ:EDAP) Share Price Crosses Above Two Hundred Day Moving Average - Should You Sell...
MarketBeat·13d ago
News Placeholder
ISRG Gets FDA Clearance to Use da Vinci SP Robot for General Surgeries
Intuitive Surgical broadens its da Vinci SP system with FDA clearance for three new surgeries, expanding its role in minimally invasive care.
Zacks·21d ago
News Placeholder
Edap Tms (NASDAQ:EDAP) Stock Price Passes Above 200 Day Moving Average - Time to Sell?
Edap Tms (NASDAQ:EDAP) Stock Crosses Above Two Hundred Day Moving Average - Time to Sell...
MarketBeat·21d ago
News Placeholder
Edap Tms (NASDAQ:EDAP) Shares Pass Above 200 Day Moving Average - Here's Why
Edap Tms (NASDAQ:EDAP) Stock Price Passes Above Two Hundred Day Moving Average - What's Next...
MarketBeat·2mo ago
News Placeholder
Natural Killer Cell Therapies Lead $254B Immunotherapy Market Transformation
Natural Killer Cell Therapies Lead $254B Immunotherapy Market Transformation Natural Killer Cell Therapies Lead $254B Immunotherapy Market Transformation PR Newswire VANCOUVER, BC, Oct. 17, 2025...
PR Newswire·3mo ago
<
...
1
>

Latest EDAP News

View

Advertisement|Remove ads.

Advertisement|Remove ads.